Capsugel Logo
US English CN 简体中文 JP 日本語 ES Español PT Português
Contact
Hard Empty Capsules
Encapsulated Equipment

Pharmaceutical From Standard to Specialist Capsule Formats Hard gelatin, HPMC, inhalation and vaginal formats engineered for every therapeutic need. View all →

Hard Empty Capsules
Branded Ingredients

Nutraceutical Consumer-Ready Nutraceutical Formats Capsules and branded ingredients built for supplement manufacturers who demand differentiation. Explore range →

Technologies
Health Categories

Advanced Formulation Beyond the Standard Capsule Liquid-fill, dual-release and multiparticulate technologies for complex formulations. Explore technologies →

Services
Equipment

Innovation Always One Step Ahead in Drug Delivery Latest equipment, services and technology partnerships to keep production at the cutting edge. Discover what's new →

Nutraceutical CDMO Services

CDMO Partnership

Full-Service Nutraceutical Manufacturing

From concept to market-ready product — your end-to-end nutraceutical development partner.

Learn more →

Pharmaceutical CDMO Services

Pharmaceutical CDMO

Accelerating Drug Development

Our Innovaform Accelerator and Tampa facility combine formulation science with scalable manufacturing.

Explore pharma CDMO →

Technical & Commercial Support
Quality Assurance
Company

Our Story

Partners in Drug Delivery Innovation

A global leader in capsule technologies, committed to advancing pharmaceutical and nutraceutical science.

Learn about Capsugel →

News

Lonza and Lamberti Form Commercial Collaboration in South America To Serve Personal Care Markets
Lamberti complements Lonza's portfolio with innovative hair-conditioning polymer and other productsAllendale, NJ (USA), 21 September 2015 -- Lonza's Consumer Care business unit has...
Lonza Confirms Interest in Capsugel
Basel, 12 December 2016 – Lonza Group Ltd notes the recent press speculations that it is in final negotiations with KKR regarding the potential acquisition of Capsugel. Lonza...
Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries
Strategic AdvantagesLonza to acquire Capsugel for USD 5.5 billion, including refinancing of existing Capsugel debt of USD ~2 billionAcquisition is expected to accelerate Lonza's...
Lonza akquiriert Capsugel, um führenden Anbieter von integrierten Lösungen für die globale Pharma- und Consumer-Healthcare-Branche zu schaffen
Strategische VorteileLonza akquiriert Capsugel für USD 5.5 Milliarden, einschliesslich der Refinanzierung bestehender Schulden von Capsugel in Höhe von USD ~2 MilliardenDie...
Carniking® L-Carnitine Provides Positive Impact on Performance and Recovery of Working Dogs, Study Shows
Basel, Switzerland, 18 April 2017 – New Lonza-sponsored research conducted at Four Rivers Kennel LLC, in Walker, MO (USA), demonstrates the positive impact L-Carnitine, as...
New Lonza Consumer Care Prototype Formulations Debut at NYSCC Suppliers' Day 2017: Highlight Polyaldo ® Emulsifiers and Preservatives Portfolio
South Plainfield, NJ (USA), 28 April 2017 – Five new prototype formulations from Lonza Consumer Care demonstrate the versatility of its Polyaldo® polyglyceryl esters range and...
Lonza Has Received All Regulatory Approvals to Move Forward with Acquisition of Capsugel
Basel, Switzerland, 27 June 2017 – Lonza today announced that it has received all regulatory approvals for the proposed acquisition of Capsugel S.A. by Lonza. With all final...
Lonza meldet starkes drittes Quartal und planmässigen Verlauf der Integration von Capsugel
Wie erwartet anhaltend starke Ergebnisse im dritten Quartal 2017 für Lonza auf Standalone-Basis Beide Segmente sind auf Kurs zur Erreichung der Gesamtjahresziele, die Angebote...
Serialization Capabilities Now Operational at Lonza Edinburgh Facility for Liquid-Filled Hard Capsules
Counterfeit and diverted medicines are a growing threat to patientsInvestment in former Capsugel site improves anti-counterfeiting security for Lonza's global supply chainLonza...
Lonza Partners with Prolog Ventures to Establish VC Fund to Invest in Consumer Health and Wellness Startups
Basel, Switzerland, 7 February 2018 – Lonza, one of the world's leading suppliers to the pharmaceutical, biotech and specialty ingredients industries, announced today that it has...